Skip to content

    HDFC Life Insur.

    HDFCLIFEGood
    Financial Services·15 Oct 2025
    Management Summary

    HDFC Life delivered steady H1 FY26 performance with 10% APE growth and market share gains. The GST reform announced in September was a major theme - while the exemption boosts demand (50%+ protection growth in September), the loss of input tax credit creates ~300bps annualized margin headwind. Management is confident of neutralizing this over 2-3 quarters through distributor negotiations, product mix improvements, and operational adjustments.

    Highlights

    8
    • Individual APE grew 10% YoY with 2-year CAGR of 20%; overall market share up 90bps to 11.9%

    • VNB margin at 24.5% post-GST (25% pre-GST); VNB grew 10% YoY reported, 12% pre-GST

    • Retail protection grew 27% YoY; post-GST protection growth exceeded 50% in September

    • PAT rose 9% YoY to Rs 994 crore for H1 FY26

    • Embedded Value at Rs 59,540 crore with operating RoEV of 15.8% on rolling 12-month basis

    • Solvency ratio dropped to 175% from 192% due to dividend, sub-debt retirement and GST impact

    • AUM crossed Rs 5 trillion milestone including HDFC Pension Fund subsidiary

    • GST exemption on insurance announced; management targets neutralizing input tax credit loss over 2-3 quarters

    Concerns

    1
    • GST input tax credit withdrawal causing ~300bps annualized margin headwind

    Key financials

    Metrics

    8

    Periods

    2

    Headline

    6
    • Embedded Value
      ₹59,540 Cr
    • VNB Margin (post-GST)
      24.5%
    • VNB Margin (pre-GST)
      25%
    • Operating RoEV (Rolling 12M)
      15.8%
    • Solvency Ratio
      175%

    H1

    2
    • Individual APE Growth
      10%
    • PAT
      ₹994 Cr
      YoY+9%

    Segment breakdown

    Product Mix (H1 FY26)
    42% ULIPs29% Participating Products18% Non-Par Savings7% Term4% Annuity
    Key Growth Rates
    27% Retail Protection Growth16% Annuity Growth15% Credit Life Growth (Q2)
    List

    Guidance & targets

    4
    CategoryTargetPriority
    Margins
    GST Impact Neutralization
    Neutralize ~300bps gross impact over 2-3 quarters
    High
    Margins
    VNB Margin
    Range-bound at FY25 levels; VNB growth in line with top-line
    Medium
    Growth
    Top Line Growth
    Early teens
    High
    Capital
    Subordinated Debt Raise
    Up to Rs 750 crores
    High

    Risks & concerns

    5
    RiskSeverity

    GST input tax credit withdrawal causing ~300bps annualized margin headwind

    Biggest impact on ULIP products due to charge caps. Management has 5-pronged strategy: distributor negotiations, vendor discussions, product mix improvement, new products, and volume growth.Both acknowledged

    high

    Solvency ratio declined sharply from 192% to 175% in one quarter

    Multiple factors: Rs 600cr sub-debt retirement (6%), dividend (4.5%), GST impact (1.5%), protection business strain. Plan to raise Rs 750cr sub-debt to restore to ~182%.Analyst acknowledged

    medium

    Non-par savings mix declining due to competitive pricing pressure

    Non-par mix dropped from 30%+ to 18%. Management staying away from aggressive pricing, expects pickup in H2 supported by steepening yield curve.Both acknowledged

    medium

    Fixed cost under-absorption dragging margins as growth at 10% vs 16-18% capacity

    Negative variance in VNB walk from fixed cost leverage. Will persist until growth catches up to capacitized levels.Management acknowledged

    medium

    Areas of Evasion(1)

    • Specific distributor commission details

    Q&A highlights

    3

    “annualized basis, you would expect a gross impact of about 3%... our objective is to try and neutralize that over the next couple of quarters”

    Clear quantification of 300bps gross GST impact and timeline to neutralize gives investors a framework for margin recovery

    asked by Shreya Shivani (Nomura)

    1 min read4 chapters

    Detailed Narrative

    01

    GST Reform: Short-term Pain, Long-term Gain

    The GST exemption on insurance premiums announced September 3rd is the dominant theme. While structurally positive for demand (50%+ protection growth in September), the loss of input tax credit creates ~300bps annualized margin headwind, with biggest impact on ULIPs. Management has a multi-pronged approach: distributor renegotiation, vendor cost discussions, product mix shift towards protection and high-SA ULIPs, new products like variable annuity, and volume growth leverage.

    02

    Product Mix Evolution and Margin Levers

    ULIPs at 42% of mix with ~25% now in higher sum assured variants that deliver margins converging towards par products. Non-par at 18%, down from 30%+ due to competitive pricing discipline. Protection grew 27% with sum assured CAGR of 26% over two years. The product-level margin improvement of 110bps more than offset the apparent negative product mix shift. Agency channel at 9% of APE but with higher margins than company average.

    03

    Solvency and Capital Management

    Solvency dropped 17pp from 192% to 175% due to Rs 600cr sub-debt retirement (6%), dividend (4.5%), GST impact (1.5%), and protection business strain. Plan to raise Rs 750cr sub-debt in H2 to restore to ~182%. Management comfortable operating at 170-185% under current regime and expects risk-based capital transition over 12-18 months to improve solvency optics significantly. No equity capital needed for organic growth.

    04

    Distribution Dynamics

    HDFC Bank counter share stable with 2-year CAGR of 20%. Other bank partnerships saw some counter share pressure in Q1 from open architecture additions but recovered in Q2. Agency channel delivered double-digit growth with 2-year CAGR of ~20%, with 50,000+ agents added in H1 (80% from Tier 2/3). Broker channel grew to 9% of APE with healthy margins. Tier 2/3 markets contribute two-thirds to 70% of APE.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.